SIBN Competitors

SIBN Stock  USD 16.55  0.19  1.14%   
Si Bone competes with Orthofix Medical, Pacific Biosciences, Clearpoint Neuro, Butterfly Network, and InnovAge Holding; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Si Bone competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Si Bone to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Si Bone Correlation with its peers.
To learn how to invest in SIBN Stock, please use our How to Invest in Si Bone guide.

Si Bone vs Varex Imaging Correlation

Good diversification

The correlation between Si Bone and VREX is -0.19 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Si Bone and VREX in the same portfolio, assuming nothing else is changed.

Moving against SIBN Stock

  0.69ZTLLF ZonetailPairCorr
  0.65CUPR Cuprina HoldingsPairCorr
  0.61NSFDF NXT Energy SolutionsPairCorr
  0.57TELNY Telenor ASA ADRPairCorr
  0.56GLABF Gemina LaboratoriesPairCorr
As of the 29th of January 2026, Return On Tangible Assets is likely to drop to -0.13. In addition to that, Return On Capital Employed is likely to grow to -0.16. At this time, Si Bone's Asset Turnover is very stable compared to the past year.
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
12.9516.3519.75
Details
Intrinsic
Valuation
LowRealHigh
15.4318.8322.23
Details
Naive
Forecast
LowNextHigh
12.8416.2419.64
Details
9 Analysts
Consensus
LowTargetHigh
23.1125.4028.19
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Si Bone. Your research has to be compared to or analyzed against Si Bone's peers to derive any actionable benefits. When done correctly, Si Bone's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Si Bone.

Si Bone Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Si Bone and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of SIBN and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Si Bone does not affect the price movement of the other competitor.

High positive correlations

AVXLAIRS
AIRSCLPT
AVXLCLPT
VREXAVNS
AQSTOFIX
VREXBFLY
  

High negative correlations

VREXAQST
AQSTAVNS
AIRSBFLY
AQSTBFLY
AIRSINNV
AQSTINNV

Risk-Adjusted Indicators

There is a big difference between SIBN Stock performing well and Si Bone Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Si Bone's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
OFIX  1.60 (0.37) 0.00 (0.20) 0.00 
 3.30 
 11.43 
PACB  4.94  0.40  0.08  0.41  4.64 
 10.80 
 31.33 
CLPT  3.81 (0.94) 0.00 (0.48) 0.00 
 7.36 
 24.14 
BFLY  5.36  1.09  0.22  0.48  4.57 
 14.22 
 42.22 
INNV  4.11  0.23  0.03 (3.33) 5.14 
 7.78 
 32.32 
AIRS  5.49 (1.37) 0.00  3.43  0.00 
 9.30 
 50.82 
AVNS  1.62  0.08  0.04  0.15  1.79 
 4.68 
 9.85 
AVXL  4.08 (0.83) 0.00 (0.18) 0.00 
 8.16 
 41.40 
AQST  3.48 (0.92) 0.00  1.23  0.00 
 5.36 
 45.05 
VREX  1.74  0.19  0.06  0.20  3.12 
 4.43 
 18.19 

Cross Equities Net Income Analysis

Compare Si Bone and related stocks such as Orthofix Medical, Pacific Biosciences, and Clearpoint Neuro Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity
20102011201220132014201520162017201820192020202120222023202420252026
OFIXM(1.1 M)51.3 M(28.5 M)(8.5 M)(2.8 M)3.1 M6.2 M13.8 M(28.5 M)2.5 M(38.4 M)(19.7 M)(151.4 M)(126 M)(113.4 M)(107.7 M)
PACB(21.5 M)(109.4 M)(94.5 M)(79.3 M)(66.2 M)(31.7 M)(74.4 M)(92.2 M)(102.6 M)(84.1 M)29.4 M(181.2 M)(314.2 M)(306.7 M)(309.9 M)(278.9 M)(264.9 M)
CLPT(9.5 M)(8.3 M)(5.7 M)(7.1 M)(4.5 M)(8.4 M)(8.1 M)(7.2 M)(6.2 M)(5.5 M)(6.8 M)(14.4 M)(16.4 M)(22.1 M)(18.9 M)(17 M)(16.2 M)
BFLY(50.8 M)(50.8 M)(50.8 M)(50.8 M)(50.8 M)(50.8 M)(50.8 M)(50.8 M)(50.8 M)(99.6 M)(162.7 M)(32.4 M)(168.7 M)(133.7 M)(72.5 M)(65.2 M)(68.5 M)
INNV(4.8 M)(4.8 M)(4.8 M)(4.8 M)(4.8 M)(4.2 M)(13.7 M)(6.5 M)19.6 M26.3 M(44 M)(6.5 M)(40.7 M)(21.3 M)(30.3 M)(27.3 M)(25.9 M)
AIRS(2.2 M)(2.2 M)(2.2 M)(2.2 M)(2.2 M)(2.2 M)(2.2 M)(2.2 M)(2.2 M)(2.2 M)7.6 M10.6 M(14.7 M)(4.5 M)(8.3 M)(7.4 M)(7.1 M)
AVNS142.4 M142.4 M152.6 M154.6 M27.1 M(426.3 M)39.8 M79.3 M57.5 M(45.9 M)(27.2 M)6.3 M50.5 M(61.8 M)(392.1 M)(352.9 M)(335.2 M)
AVXL(14.4 K)(8.3 M)(3.7 M)(11.4 M)(12.1 M)(14.7 M)(13.5 M)(17.5 M)(26.3 M)(26.3 M)(37.9 M)(48 M)(47.5 M)(43 M)(46.4 M)(41.7 M)(39.7 M)
AQST(8.3 M)(9.6 M)(9.6 M)(9.6 M)(9.6 M)(9.6 M)(9.6 M)(8.9 M)(61.4 M)(66.2 M)(55.8 M)(70.5 M)(54.4 M)(7.9 M)(44.1 M)(39.7 M)(41.7 M)
VREX109.6 M109.6 M109.6 M110.1 M80 M68.5 M51.6 M27.5 M15.5 M(57.9 M)17.4 M30.3 M48.2 M(47.7 M)(69.9 M)(62.9 M)(59.8 M)

Si Bone and related stocks such as Orthofix Medical, Pacific Biosciences, and Clearpoint Neuro Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Si Bone financial statement analysis. It represents the amount of money remaining after all of Si Bone operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Si Bone Competitive Analysis

The better you understand Si Bone competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Si Bone's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Si Bone's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
SIBN OFIX PACB CLPT BFLY INNV AIRS AVNS AVXL AQST
 1.14 
 16.55 
SIBN
 0.08 
 13.13 
Orthofix
 0.42 
 2.37 
Pacific
 0.07 
 13.42 
Clearpoint
 3.71 
 4.15 
Butterfly
 3.45 
 5.69 
InnovAge
 7.05 
 2.90 
Airsculpt
 0.31 
 12.89 
Avanos
 0.82 
 4.91 
Anavex
 2.47 
 3.16 
Aquestive
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earnings To Growth
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Si Bone Competition Performance Charts

Five steps to successful analysis of Si Bone Competition

Si Bone's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Si Bone in relation to its competition. Si Bone's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Si Bone in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Si Bone's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Si Bone, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Si Bone position

In addition to having Si Bone in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Investing Thematic Idea Now

Investing
Investing Theme
Companies involved in money management and investment banking services. The Investing theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Investing Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Si Bone offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Si Bone's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Si Bone Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Si Bone Stock:
Check out Si Bone Correlation with its peers.
To learn how to invest in SIBN Stock, please use our How to Invest in Si Bone guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Will Health Care Equipment & Supplies sector continue expanding? Could SIBN diversify its offerings? Factors like these will boost the valuation of Si Bone. If investors know SIBN will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Si Bone data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.51)
Revenue Per Share
4.549
Quarterly Revenue Growth
0.206
Return On Assets
(0.07)
Return On Equity
(0.13)
Si Bone's market price often diverges from its book value, the accounting figure shown on SIBN's balance sheet. Smart investors calculate Si Bone's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Si Bone's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Si Bone's value and its price as these two are different measures arrived at by different means. Investors typically determine if Si Bone is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Si Bone's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.